Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot study

Jennifer L. Hundley, Gil Yosipovitch

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.

Original languageEnglish (US)
Pages (from-to)889-891
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume50
Issue number6
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Pruritus
Skin Diseases
Antidepressive Agents
Therapeutics
mirtazapine

ASJC Scopus subject areas

  • Dermatology

Cite this

Mirtazapine for reducing nocturnal itch in patients with chronic pruritus : A pilot study. / Hundley, Jennifer L.; Yosipovitch, Gil.

In: Journal of the American Academy of Dermatology, Vol. 50, No. 6, 01.01.2004, p. 889-891.

Research output: Contribution to journalArticle

@article{ce6977a3497e4538a5381e6453580923,
title = "Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot study",
abstract = "Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.",
author = "Hundley, {Jennifer L.} and Gil Yosipovitch",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.jaad.2004.01.045",
language = "English (US)",
volume = "50",
pages = "889--891",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Mirtazapine for reducing nocturnal itch in patients with chronic pruritus

T2 - A pilot study

AU - Hundley, Jennifer L.

AU - Yosipovitch, Gil

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.

AB - Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect. We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.

UR - http://www.scopus.com/inward/record.url?scp=2542418205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542418205&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2004.01.045

DO - 10.1016/j.jaad.2004.01.045

M3 - Article

C2 - 15153889

AN - SCOPUS:2542418205

VL - 50

SP - 889

EP - 891

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -